KIRKLAND, QC & TORONTO, ON – Today, Pfizer Canada and Rethink Breast Cancer are excited to announce the recipients of the nearly $280,000 in grants for the implementation of innovative… Read More
Approval based on MIRROR randomized controlled trial, which showed significant improvement and sustained patient response to KRYSTEXXA with methotrexate compared to KRYSTEXXA alone. Trial data showed a greater than 30… Read More
VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on… Read More
SBME’s Capstone Design course is looking for project proposals from industry clients with challenging design problems! Participating companies have benefitted by promoting their organization to UBC students and researchers, working… Read More
VANCOUVER, BC— Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it has initiated the first of 15 planned sites for CLARITY, the company’s Phase 2 clinical trial investigating psilocybin… Read More
